Bornhäuser M - Search Results

1

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhäuser M, Stelljes M, Finke J, Ganser A, Einsele H, Kröger N, Brecht A, Bethge W, Edinger M, Kulagin A, Passweg J, Blau IW, Elmaagacli A, Schäfer-Eckart K, Platzbecker U, Schroeder T, Bunjes D, Tischer J, Martin S, Spyridonidis A, Giebel S, Savani B, Mohty M. Nagler A, et al. Among authors: bornhauser m. Clin Cancer Res. 2022 Oct 3;28(19):4258-4266. doi: 10.1158/1078-0432.CCR-22-0809. Clin Cancer Res. 2022. PMID: 35670780

2

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

Bornhäuser M, Schuler U, Pörksen G, Naumann R, Geissler G, Thiede C, Schwerdtfeger R, Ehninger G, Thiede HM. Bornhäuser M, et al. Transplantation. 1999 Feb 27;67(4):499-504. doi: 10.1097/00007890-199902270-00001. Transplantation. 1999. PMID: 10071016

3

Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.

Ringdén O, Remberger M, Runde V, Bornhäuser M, Blau IW, Basara N, Hölig K, Beelen DW, Hägglund H, Basu O, Ehninger G, Fauser AA. Ringdén O, et al. Among authors: bornhauser m. Blood. 1999 Jul 15;94(2):455-64. Blood. 1999. PMID: 10397713 Free article. Clinical Trial.

4

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin.

Bornhäuser M, Thiede C, Schuler U, Platzbecker U, Freiberg-Richter J, Helwig A, Plettig R, Röllig C, Naumann R, Kroschinsky F, Neubauer A, Ehninger G. Bornhäuser M, et al. Bone Marrow Transplant. 2000 Jul;26(2):119-25. doi: 10.1038/sj.bmt.1702500. Bone Marrow Transplant. 2000. PMID: 10918420

5

Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.

Ringdén O, Remberger M, Runde V, Bornhäuser M, Blau IW, Basara N, Hölig K, Beelen DW, Hägglund H, Basu O, Ehninger G, Fauser AA. Ringdén O, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2000 May;25 Suppl 2:S6-8. doi: 10.1038/sj.bmt.1702343. Bone Marrow Transplant. 2000. PMID: 10933177 Clinical Trial.

6

Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.

Scheulen ME, Hilger RA, Oberhoff C, Casper J, Freund M, Josten KM, Bornhäuser M, Ehninger G, Berdel WE, Baumgart J, Harstrick A, Bojko P, Wolf HH, Schindler AE, Seeber S. Scheulen ME, et al. Among authors: bornhauser m. Clin Cancer Res. 2000 Nov;6(11):4209-16. Clin Cancer Res. 2000. PMID: 11106234 Clinical Trial.

7

Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin.

Platzbecker U, Klingel K, Thiede C, Freiberg-Richter J, Schuh D, Ehninger G, Kandolf R, Bornhäuser M. Platzbecker U, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2001 Jan;27(1):107-9. doi: 10.1038/sj.bmt.1702744. Bone Marrow Transplant. 2001. PMID: 11244447

8

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.

Platzbecker U, Thiede C, Freiberg-Richter J, Röllig C, Helwig A, Schäkel U, Mohr B, Schaich M, Ehninger G, Bornhäuser M. Platzbecker U, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2001 Mar;27(5):543-6. doi: 10.1038/sj.bmt.1702819. Bone Marrow Transplant. 2001. PMID: 11313690

9

Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF.

Platzbecker U, Thiede C, Freiberg-Richter J, Helwig A, Mohr B, Prange G, Füssel M, Köhler T, Ehninger G, Bornhäuser M. Platzbecker U, et al. Among authors: bornhauser m. Ann Hematol. 2001 Mar;80(3):144-9. doi: 10.1007/s002770000258. Ann Hematol. 2001. PMID: 11320898

10

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.

Platzbecker U, Bandt D, Thiede C, Helwig A, Freiberg-Richter J, Schuler U, Plettig R, Geissler G, Rethwilm A, Ehninger G, Bornhäuser M. Platzbecker U, et al. Among authors: bornhauser m. Transplantation. 2001 Apr 15;71(7):880-5. doi: 10.1097/00007890-200104150-00010. Transplantation. 2001. PMID: 11349720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

653 results

Search Page